EUTM file information

019088445

AraLinQ


October 7, 2024

Trademark Summary

The trademark application AraLinQ was filed by Araris Biotech AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). Application under examination.

The application was filed in German (English was selected as the second language).


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemicals, Biochemicals, Biologicals, Molecular genetic products, for laboratory analysis and industrial use, Science
    2. Reagents and bioactive compounds
    3. Peptides, Peptide derivatives Proteins, Glycans, Nucleotides, Lipids, Antibodies, Antibody active substance conjugates, Antibody fragments, antibody derivatives, Nucleic acids, DNA, vectors
    4. Chemical preparations, biochemical preparations, Biological preparations, Biotechnological preparations, Molecular genetic preparations, For industrial purposes, Science
    5. Chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins, for the development or manufacture of reagents, For industrial purposes, Science
    6. Biological preparations, namely Polypeptides, Peptide derivatives or Proteins, for laboratory use, For analysis purposes, For industrial purposes, Science
    7. Chemical and biochemical substances for manufacturing pharmaceutical goods.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals, medical preparations
    2. Pharmaceuticals and Medical preparations, for use in the following fields: Cancer treatment
    3. Biopharmaceutical products and Medical preparations, for use in the following fields: Antibody active substance conjugates
    4. Chemical products, Biological products, Molecular genetic products, Biochemical products, biopharmaceutical products, For medical purposes, for pharmaceutical purposes, namely Peptides, Peptide derivatives, proteins, Antibodies, Antibody active substance conjugates, Antibody fragments, antibody derivatives, Nucleic acids, DNA, vectors
    5. Pharmaceutical products and substances for the treatment of illnesses and preparations for medical treatments.